Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06516653Not ApplicableRecruiting

Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula

Role: lead

NCT03246984Not ApplicableCompleted

VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ

Role: lead

NCT03242343Not ApplicableCompleted

VasQ External Support for Arteriovenous Fistula

Role: lead

NCT04141852Not ApplicableCompleted

VasQ and Hemodynamic Conditions in AVFs

Role: collaborator

NCT02112669Not ApplicableCompleted

A Multi Center, Study to Evaluate the Safety and Efficacy of the VasQ External Support Device for Arteriovenous Fistulas

Role: lead

All 5 trials loaded